@article{fox:hal-03675513, TITLE = {{Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry}}, AUTHOR = {Fox, Keith and Aboyans, Victor and Debus, E Sebastian and Zeymer, Uwe and Cowie, Martin and Patel, Manesh and Welsh, Robert and Bosch, Jackie and Gay, Alain and Vogtl{\"a}nder, Kai and Anand, Sonia}, URL = {https://unilim.hal.science/hal-03675513}, JOURNAL = {{European Heart Journal - Cardiovascular Pharmacotherapy}}, PUBLISHER = {{Oxford Academy}}, YEAR = {2022}, MONTH = May, DOI = {10.1093/ehjcvp/pvac028}, KEYWORDS = {Cardiovascular disease ; Coronary artery disease ; Peripheral artery disease ; Real-world evidence}, HAL_ID = {hal-03675513}, HAL_VERSION = {v1}, }